---
title: "The concept of weight loss drugs continues to rise, CSBIO hits the daily limit of 20cm"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248081219.md"
description: "The concept of weight loss drugs continues to rise, CSBIO hits the daily limit, and Kailaiying, Medicy, Jinkaishengke, Borui Pharmaceutical, Nuotai Biological, and Nawei Technology follow suit"
datetime: "2025-07-11T01:54:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248081219.md)
  - [en](https://longbridge.com/en/news/248081219.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248081219.md)
generator: "portal-rs"
---

# The concept of weight loss drugs continues to rise, CSBIO hits the daily limit of 20cm

The concept of weight loss drugs continues to rise, CSBIO hits the daily limit, and companies such as Kelaiying, Medicy, Jinkaishengke, Borui Pharmaceutical, Nuotai Biotechnology, and Nawei Technology also see gains

### Related Stocks

- [300255.CN](https://longbridge.com/en/quote/300255.CN.md)

## Related News & Research

- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)
- [RCS - ZAGENO - ZAGENO and ORO Labs Partnership](https://longbridge.com/en/news/297046609.md)
- [China's FAW, Leapmotor sign agreement to deepen strategic cooperation](https://longbridge.com/en/news/296793126.md)
- [BMS Holdings Q4 FY2026 PAT Rises 106.5% QoQ to RM5.04 Million](https://longbridge.com/en/news/296892849.md)
- [Qlife enters fully funded feasibility deal with global pharma company for Egoo Health biomarker application](https://longbridge.com/en/news/296995766.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**